
We assessed the clinical relevance and performed molecular characterization of 36 multidrug-resistant strains of Corynebacterium striatum. Pulsed-field gel electrophoresis confirmed a single clone, possessing erm(X), tetA/B, cmxA/B, and aphA1 genes, but few related subclones. This strain is emerging as a pathogen in Italy.
Corynebacterium striatum, Bacteremia, Infectious and parasitic diseases, RC109-216, Microbial Sensitivity Tests, Corynebacterium, Communicable Diseases, Emerging, Ribotyping, Bacterial Proteins, Drug Resistance, Multiple, Bacterial, multi-resistance plasmid pTP10, Pneumonia, Bacterial, Humans, emerging clinical role, Corynebacterium Infections, R, Dispatch, dispatch, Anti-Bacterial Agents, Electrophoresis, Gel, Pulsed-Field, Italy, Wound Infection, Medicine
Corynebacterium striatum, Bacteremia, Infectious and parasitic diseases, RC109-216, Microbial Sensitivity Tests, Corynebacterium, Communicable Diseases, Emerging, Ribotyping, Bacterial Proteins, Drug Resistance, Multiple, Bacterial, multi-resistance plasmid pTP10, Pneumonia, Bacterial, Humans, emerging clinical role, Corynebacterium Infections, R, Dispatch, dispatch, Anti-Bacterial Agents, Electrophoresis, Gel, Pulsed-Field, Italy, Wound Infection, Medicine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 72 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
